Onasemnogene Abeparvovec vs Trastuzumab

## Onasemnogene Abeparvovec vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Onasemnogene Abeparvovec** and **Trastuzumab**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Onasemnogene Abeparvovec — N/A; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Onasemnogene Abeparvovec — Gene; Trastuzumab — Antibody.